Dário Ligeiro

Dário Ligeiro

Auto-generated profile, based on publicly available information

Dário Ligeiro

Lisbon Centre for Blood and Transplantation, Instituto Português do Sangue e Transplantação, Lisbon, Portugal

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2014 in Molecular Oncology
Verified
Journal Article
Open access
Mylène CarrascalMylène Carrascal
Mylène Carrascal
PSPaulo F. Severino
Paulo F. Severino
MCMaria Guadalupe Cabral
Maria Guadalupe Cabral
MSMariana Silva
Mariana Silva
José Alexandre FerreiraJosé Alexandre Ferreira
José Alexandre Ferreira
PVPaula Videira
Paula Videira
Despite the wide acceptance that glycans are centrally implicated in immunity, exactly how they contribute to the tilt immune response remains poorly defined. In this study, we sought to evaluate the impact of the malignant phenotype‐associated glycan, sialyl‐Tn (STn) in the function of the key orchestrators of the immune response, the dendritic cells (DCs). In high grade bladder cancer tissue, the STn antigen is significantly overexpressed and correlated with the increased expression of ST6GALNAC1 sialyltransferase. Bladder cancer tissue presenting elevated expression of ST6GALNAC1 showed a correlation with increased expression of CD1a, a marker for bladder immature DCs and showed concomitant low levels of Th1‐inducing cytokines IL‐12 and TNF‐α. In vitro, human DCs co‐incubated with STn+ bladder cancer cells, had an immature phenotype (MHC‐IIlow, CD80low and CD86low) and were unresponsive to further maturation stimuli. When contacting with STn+ cancer cells, DCs expressed significantly less IL‐12 and TNF‐α. Consistent with a tolerogenic DC profile, T cells that were primed by DCs pulsed with antigens derived from STn+ cancer cells were not activated and showed a FoxP3high IFN‐γlow phenotype. Blockade of STn antigens and of STn+ glycoprotein, CD44 and MUC1, in STn+ cancer cells was able to lower the induction of tolerance and DCs become more mature.Overall, our data suggest that STn‐expressing cancer cells impair DC maturation and endow DCs with a tolerogenic function, limiting their capacity to trigger protective anti‐tumour T cell responses. STn antigens and, in particular, STn+ glycoproteins are potential targets for circumventing tumour‐induced tolerogenic mechanisms.

7 October 2009 in BMC Cancer
Verified
Journal Article
Open access
PDF file
PVPaula Videira
Paula Videira
MCManuela Correia
Manuela Correia
NMNadia Malagolini
Nadia Malagolini
HCHélio J Crespo
Hélio J Crespo
DLDário Ligeiro
Dário Ligeiro
Fabio Dall'olioFabio Dall'olio
Fabio Dall'olio
The T antigen is a tumor-associated structure whose sialylated form (the sialyl-T antigen) involves the altered expression of sialyltransferases and has been related with worse prognosis. Since little or no information is available on this subject, we investigated the regulation of the sialyltransferases, able to sialylate the T antigen, in bladder cancer progression.

7 April 2011 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
FPFernando Manuel Pimnetel-Santos
Fernando Manuel Pimnetel-Santos
DLDário Ligeiro
Dário Ligeiro
MMMafalda Matos
Mafalda Matos
AMAna F Mourão
Ana F Mourão
JCJosé Costa
José Costa
GTGethin P Thomas
Gethin P Thomas
Introduction: A number of genetic-association studies have identified genes contributing to ankylosing spondylitis (AS) susceptibility but such approaches provide little information as to the gene activity changes occurring during the disease process. Transcriptional profiling generates a 'snapshot' of the sampled cells' activity and thus can provide insights into the molecular processes driving the disease process. We undertook a whole-genome microarray approach to identify candidate genes associated with AS and validated these gene-expression changes in a larger sample cohort.Methods: A total of 18 active AS patients, classified according to the New York criteria, and 18 gender- and age-matched controls were profiled using Illumina HT-12 whole-genome expression BeadChips which carry cDNAs for 48,000 genes and transcripts. Class comparison analysis identified a number of differentially expressed candidate genes. These candidate genes were then validated in a larger cohort using qPCR-based TaqMan low density arrays (TLDAs).Results: A total of 239 probes corresponding to 221 genes were identified as being significantly different between patients and controls with aP-value <0.0005 (80% confidence level of false discovery rate). Forty-seven genes were then selected for validation studies, using the TLDAs. Thirteen of these genes were validated in the second patient cohort with 12 downregulated 1.3- to 2-fold and only 1 upregulated (1.6-fold). Among a number of identified genes with well-documented inflammatory roles we also validated genes that might be of great interest to the understanding of AS progression such asSPOCK2(osteonectin) andEP300, which modulate cartilage and bone metabolism.Conclusions: We have validated a gene expression signature for AS from whole blood and identified strong candidate genes that may play roles in both the inflammatory and joint destruction aspects of the disease.

1 September 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
ESEric de Sousa
Eric de Sousa
DLDário Ligeiro
Dário Ligeiro
JLJoana Lerias
Joana Lerias
CZChao Zhang
Chao Zhang
CAChiara Agrati
Chiara Agrati
MMMarkus Maeurer
Markus Maeurer
Genetic factors such as the HLA type of patients may play a role in regard to disease severity and clinical outcome of patients with COVID-19. Taking the data deposited in the GISAID database, we made predictions using the IEDB analysis resource (TepiTool) to gauge how variants in the SARS-CoV-2 genome may change peptide binding to the most frequent MHC-class I and -II alleles in Africa, Asia and Europe. We caracterized how a single mutation in the wildtype sequence of of SARS-CoV-2 could influence the peptide binding of SARS-CoV-2 variants to MHC class II, but not to MHC class I alleles. Assuming the ORF8 (L84S) mutation is biologically significant, selective pressure from MHC class II alleles may select for viral varients and subsequently shape the quality and quantity of cellular immune responses aginast SARS-CoV-2. MHC 4-digit typing along with viral sequence analysis should be considered in studies examining clinical outcomes in patients with COVID-19.

1 May 2005 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
João Eurico FonsecaJoão Eurico Fonseca
João Eurico Fonseca
TCT Carvalho
T Carvalho
MCM Cruz
M Cruz
PNP Nero
P Nero
MSM Sobral
M Sobral
Jaime BrancoJaime Branco
Jaime Branco
To evaluate the influence of the polymorphism at position −308 of the TNFα gene in the long term response to infliximab, we performed a prospective study of 22 consecutive patients with RA who were given infliximab treatment. All patients fulfilled the American College of Rheumatology 1987 revised criteria for RA4 and had a Disease Activity Score in 28 joints (DAS28)5 persistently above 3.2 after treatment with methotrexate 20 mg/week for 3 months, according to the guidelines of the Portuguese Society for Rheumatology.6

1 October 2009 in Urology
Verified
Journal Article
Closed access
PVPaula Videira
Paula Videira
FCFernando M. Calais
Fernando M. Calais
MCManuela Correia
Manuela Correia
DLDário Ligeiro
Dário Ligeiro
HCHélio J. Crespo
Hélio J. Crespo
HTHélder Trindade
Hélder Trindade